Leap Therapeutics, Inc.
LPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $108,146 | $84,643 | $50,958 | $278,074 |
| - Cash | $47,249 | $70,643 | $20,993 | $114,916 |
| + Debt | $266 | $262 | $524 | $469 |
| Enterprise Value | $61,163 | $14,262 | $30,489 | $163,627 |
| Revenue | $0 | $0 | $0 | $1,500 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$427 | $0 | $1,500 |
| % Margin | – | – | – | 100% |
| EBITDA | -$70,052 | -$80,987 | -$54,379 | -$40,541 |
| % Margin | – | – | – | -2,702.7% |
| Net Income | -$67,555 | -$81,414 | -$54,596 | -$40,587 |
| % Margin | – | – | – | -2,705.8% |
| EPS Diluted | -1.81 | -3.98 | -4.82 | -4.73 |
| % Growth | 54.5% | 17.4% | -1.9% | – |
| Operating Cash Flow | -$60,299 | -$43,753 | -$49,044 | -$35,157 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$60,299 | -$43,753 | -$49,044 | -$35,157 |